ABL manufacture and characterization services (MCS) for vaccines and other biologics for infectious diseases
Active Awarded Last action
- Contract number
- 75N93022F00001
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,752,675
Award facts
- Contract value 100% obligated
- $3,752,675.43 Current and potential, with all options
- Completion date 99% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $126,701 | |
| Funding Only Action | $464,615 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $101,023 | |
| Supplemental Agreement for work within scope | $1,329,820 | |
| Original award | $1,730,516 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on May 15, 2022, with a ceiling value of $3,752,675.43 for manufacture and characterization services for vaccines and other biologics for infectious diseases.
Place of performance is Rockville, MD. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of October 31, 2026. Advanced Bioscience Laboratories is a foreign-owned manufacturer specializing in contract research and manufacturing for gene therapies, vaccines, and immunotherapies, with extensive prior work across multiple NIH institutes including NIAID, NCI, and NINDS.
In FY2024, the order invoiced $784,000 across 0.8 FTEs and 1,553 contractor hours, representing a derived government-paid hourly rate of $504.57 per hour. The prime self-performed all reported hours with no subcontractor engagement.
Quick answers
Who was awarded contract 75N93022F00001?
75N93022F00001 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 15, 2022.
How much is contract 75N93022F00001 worth?
The government has obligated $3,752,675 on 75N93022F00001.
Is contract 75N93022F00001 an order under another contract?
Yes. 75N93022F00001 is a delivery order under 75N93018D00009, an indefinite delivery contract.
Was contract 75N93022F00001 competed?
The extent of competition for 75N93022F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award